Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!

Liraglutide is indicated for the treatment of insufficiently controlled type 2 diabetes. PITTSBURGH — Generic drug maker Mylan is challenging the patent on a drug used to treat diabetes, the company ...

Biocon said its arm, Biocon Pharma, has received approval from the U.S. Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Liraglutide injection (gVictoza), 18 mg ...

While Liraglutide provides immediate momentum, the industry is eyeing 2031, the year Semaglutide patents expire in the US and Europe.

Biocon Limited's wholly owned subsidiary Biocon Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application ...

New research suggests the risks tied to early pregnancy exposure to popular weight loss drugs may not be the same for every patient.

The study also reported a 42% lower risk of psychiatric hospitalizations and work absences during periods when patients were ...

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with one type of drug.

CESC said it has incorporated four new wholly owned subsidiaries Purvah Navurja, Purvah Cleantech, Purvah Bikaner-V One Power and Purvah Clean Energy. Adani Energy Solutions said its arm Adani ...

Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just ...

A new study suggests drugs such as Ozempic and Wegovy may help alleviate symptoms of anxiety and depression, with semaglutide linked to significantly reduced risk of worsening mental health ...

A major new study finds people with type 1 diabetes face nearly three times the dementia risk. But lifestyle changes and new ...